B+
Bull case
20%
Probability
Target price
$1.10
Analysis reference price unavailable
Analysis 2026-04-15 · RankAlpha Sentiment Codex
TRIB
Trinity BiotechFNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
If CGM+ milestones become dated and credible while the post-restructuring diagnostics base stays cash generative, TRIB’s tiny market cap leaves room for outsized upside on proof-of-execution.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.0.
What can break
2024 Form 20-F shows continued losses, thin cash relative to liabilities, and negative equity.
Momentum
64
Value
44
Sentiment
26
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.60 · Bull $1.10 · Bear $0.30Analysis 2026-04-15; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-08-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-08-18
Investment thesis
As of 2026-08-18
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-08-18. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Why
Momentum64 · Δ7d -
Value44 · Δ7d -0.0
Sentiment26 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta -0.0.
Contradictions & invalidation
- • 2024 Form 20-F shows continued losses, thin cash relative to liabilities, and negative equity.
- • CGM+ remains development-stage and depends on successful pivotal-trial execution and regulatory progress.
- • The current setup is still fragile: low evidence quality in the packet, unresolved listing pressure, weak balance-sheet cushion, and a growth thesis leaning heavily on future CGM milestones that are not yet externally validated.
Catalyst clock
2026-08-18
Nasdaq MVPHS compliance clock remains an overhang [#PR-2026-02-20]
Lead driver: Value · See fundamentals
Momentum
64
10% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
44
40% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+7.5
Sentiment
26
49% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 63.9 / Value 44.0 / Sentiment 25.6
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-04-15. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$0.60
Analysis reference price unavailable
Analysis 2026-04-15 · RankAlpha Sentiment Codex
B-
Bear case
35%
Probability
Target price
$0.30
Analysis reference price unavailable
Analysis 2026-04-15 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$7.2M
Beta
0.62
Shares Out
644.6K
P/E (TTM) · Derived
-0.2
P/S (TTM)
0.29
P/FCF (TTM) · Derived
-32.52
Rev YoY
+43.1%
EPS YoY
-52.5%
Gross Margin
+35.4%
Op Margin
-48.8%
Net Debt
$132.85M
Current Ratio
0.25
As of 2026-08-18 • Updated nightlySource: Internal modelMethods & Data